CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 76 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q3 2020. The put-call ratio across all filers is 2.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $471,000 | -1.7% | 25,600 | -1.9% | 0.00% | – |
| Q3 2020 | $479,000 | +28.4% | 26,100 | +4.8% | 0.00% | – |
| Q2 2020 | $373,000 | -1.8% | 24,900 | +3.8% | 0.00% | – |
| Q1 2020 | $380,000 | -2.6% | 24,000 | 0.0% | 0.00% | – |
| Q4 2019 | $390,000 | +38.3% | 24,000 | +26.3% | 0.00% | – |
| Q3 2019 | $282,000 | -10.2% | 19,000 | 0.0% | 0.00% | – |
| Q2 2019 | $314,000 | -16.7% | 19,000 | -12.8% | 0.00% | – |
| Q1 2019 | $377,000 | +12.2% | 21,788 | +14.7% | 0.00% | – |
| Q4 2018 | $336,000 | -2.6% | 19,000 | 0.0% | 0.00% | – |
| Q3 2018 | $345,000 | -7.0% | 19,000 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $371,000 | +11.4% | 19,000 | 0.0% | 0.00% | – |
| Q1 2018 | $333,000 | +54.2% | 19,000 | 0.0% | 0.00% | – |
| Q4 2017 | $216,000 | +6.9% | 19,000 | 0.0% | 0.00% | – |
| Q3 2017 | $202,000 | +21.7% | 19,000 | 0.0% | 0.00% | – |
| Q2 2017 | $166,000 | -25.9% | 19,000 | 0.0% | 0.00% | – |
| Q1 2017 | $224,000 | -10.0% | 19,000 | 0.0% | 0.00% | – |
| Q4 2016 | $249,000 | -9.8% | 19,000 | 0.0% | 0.00% | – |
| Q3 2016 | $276,000 | +21.1% | 19,000 | 0.0% | 0.00% | – |
| Q2 2016 | $228,000 | -35.6% | 19,000 | 0.0% | 0.00% | -100.0% |
| Q1 2016 | $354,000 | -5.6% | 19,000 | +90.0% | 0.00% | 0.0% |
| Q2 2015 | $375,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|